Biocon Biologics receives upgrade in LT issuer credit rating
From S&P Global Ratings
Biocon Biologics, subsidiary of Biocon today announced that S&P Global Ratings has upgraded the Company's long-term issuer credit rating to BB+' from BB', and revised the outlook to Stable. The rating on the senior secured notes issued by Biocon Biologics Global PLC has also been upgraded to BB+'.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content